# Study to Evaluate the Long-term Safety of a Once-Daily Omiganan Topical Gel

> **NCT02576847** · PHASE3 · COMPLETED · sponsor: **Maruho Co., Ltd.** · enrollment: 307 (actual)

## Conditions studied

- Rosacea

## Interventions

- **DRUG:** Omiganan

## Key facts

- **NCT ID:** NCT02576847
- **Lead sponsor:** Maruho Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10
- **Primary completion:** 2017-07-14
- **Final completion:** 2018-02-08
- **Target enrollment:** 307 (ACTUAL)
- **Last updated:** 2022-07-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02576847

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02576847, "Study to Evaluate the Long-term Safety of a Once-Daily Omiganan Topical Gel". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02576847. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*